187 related articles for article (PubMed ID: 27861732)
1. Shuttle-mediated nanoparticle transport across an in vitro brain endothelium under flow conditions.
Falanga AP; Pitingolo G; Celentano M; Cosentino A; Melone P; Vecchione R; Guarnieri D; Netti PA
Biotechnol Bioeng; 2017 May; 114(5):1087-1095. PubMed ID: 27861732
[TBL] [Abstract][Full Text] [Related]
2. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
Wang YI; Abaci HE; Shuler ML
Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
[TBL] [Abstract][Full Text] [Related]
3. Effect of flow on targeting and penetration of angiopep-decorated nanoparticles in a microfluidic model blood-brain barrier.
Papademetriou I; Vedula E; Charest J; Porter T
PLoS One; 2018; 13(10):e0205158. PubMed ID: 30300391
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis and Characterization of Novel Co-Polymers Decorated with Peptides for the Selective Nanoparticle Transport across the Cerebral Endothelium.
Falanga AP; Melone P; Cagliani R; Borbone N; D'Errico S; Piccialli G; Netti PA; Guarnieri D
Molecules; 2018 Jul; 23(7):. PubMed ID: 29986452
[TBL] [Abstract][Full Text] [Related]
5. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
[TBL] [Abstract][Full Text] [Related]
6. Peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood-brain barrier in rats.
Valiante S; Falanga A; Cigliano L; Iachetta G; Busiello RA; La Marca V; Galdiero M; Lombardi A; Galdiero S
Int J Nanomedicine; 2015; 10():1885-98. PubMed ID: 25792823
[TBL] [Abstract][Full Text] [Related]
7. An in vitro and in vivo study of peptide-functionalized nanoparticles for brain targeting: The importance of selective blood-brain barrier uptake.
Bode GH; Coué G; Freese C; Pickl KE; Sanchez-Purrà M; Albaiges B; Borrós S; van Winden EC; Tziveleka LA; Sideratou Z; Engbersen JFJ; Singh S; Albrecht K; Groll J; Möller M; Pötgens AJG; Schmitz C; Fröhlich E; Grandfils C; Sinner FM; Kirkpatrick CJ; Steinbusch HWM; Frank HG; Unger RE; Martinez-Martinez P
Nanomedicine; 2017 Apr; 13(3):1289-1300. PubMed ID: 27884636
[TBL] [Abstract][Full Text] [Related]
8. Enhanced uptake of gH625 by blood brain barrier compared to liver in vivo: characterization of the mechanism by an in vitro model and implications for delivery.
Falanga A; Iachetta G; Lombardi L; Perillo E; Lombardi A; Morelli G; Valiante S; Galdiero S
Sci Rep; 2018 Sep; 8(1):13836. PubMed ID: 30218088
[TBL] [Abstract][Full Text] [Related]
9. Phage display as a tool to discover blood-brain barrier (BBB)-shuttle peptides: panning against a human BBB cellular model.
Díaz-Perlas C; Sánchez-Navarro M; Oller-Salvia B; Moreno M; Teixidó M; Giralt E
Biopolymers; 2017 Jan; 108(1):. PubMed ID: 27486695
[TBL] [Abstract][Full Text] [Related]
10. A method for evaluating nanoparticle transport through the blood-brain barrier in vitro.
Guarnieri D; Muscetti O; Netti PA
Methods Mol Biol; 2014; 1141():185-99. PubMed ID: 24567140
[TBL] [Abstract][Full Text] [Related]
11. Shuttle-mediated nanoparticle delivery to the blood-brain barrier.
Guarnieri D; Falanga A; Muscetti O; Tarallo R; Fusco S; Galdiero M; Galdiero S; Netti PA
Small; 2013 Mar; 9(6):853-62. PubMed ID: 23135878
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB).
Booth R; Kim H
Lab Chip; 2012 Apr; 12(10):1784-92. PubMed ID: 22422217
[TBL] [Abstract][Full Text] [Related]
13. Surface decoration with gH625-membranotropic peptides as a method to escape the endo-lysosomal compartment and reduce nanoparticle toxicity.
Guarnieri D; Muscetti O; Falanga A; Fusco S; Belli V; Perillo E; Battista E; Panzetta V; Galdiero S; Netti PA
Nanotechnology; 2015 Oct; 26(41):415101. PubMed ID: 26403519
[TBL] [Abstract][Full Text] [Related]
14. Ultrathin Silicon Membranes for
Hudecz D; Khire T; Chung HL; Adumeau L; Glavin D; Luke E; Nielsen MS; Dawson KA; McGrath JL; Yan Y
ACS Nano; 2020 Jan; 14(1):1111-1122. PubMed ID: 31914314
[TBL] [Abstract][Full Text] [Related]
15. Chemically synthesized peptide libraries as a new source of BBB shuttles. Use of mass spectrometry for peptide identification.
Guixer B; Arroyo X; Belda I; Sabidó E; Teixidó M; Giralt E
J Pept Sci; 2016 Sep; 22(9):577-91. PubMed ID: 27440580
[TBL] [Abstract][Full Text] [Related]
16. PLGA nanoparticles prepared by nano-emulsion templating using low-energy methods as efficient nanocarriers for drug delivery across the blood-brain barrier.
Fornaguera C; Dols-Perez A; Calderó G; García-Celma MJ; Camarasa J; Solans C
J Control Release; 2015 Aug; 211():134-43. PubMed ID: 26057857
[TBL] [Abstract][Full Text] [Related]
17. New experimental models of the blood-brain barrier for CNS drug discovery.
Kaisar MA; Sajja RK; Prasad S; Abhyankar VV; Liles T; Cucullo L
Expert Opin Drug Discov; 2017 Jan; 12(1):89-103. PubMed ID: 27782770
[TBL] [Abstract][Full Text] [Related]
18. In vivo biodistribution of prion- and GM1-targeted polymersomes following intravenous administration in mice.
Stojanov K; Georgieva JV; Brinkhuis RP; van Hest JC; Rutjes FP; Dierckx RA; de Vries EF; Zuhorn IS
Mol Pharm; 2012 Jun; 9(6):1620-7. PubMed ID: 22536790
[TBL] [Abstract][Full Text] [Related]
19. Crossing the blood-brain barrier with nanoparticles.
Zhou Y; Peng Z; Seven ES; Leblanc RM
J Control Release; 2018 Jan; 270():290-303. PubMed ID: 29269142
[TBL] [Abstract][Full Text] [Related]
20. Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review.
Lossinsky AS; Shivers RR
Histol Histopathol; 2004 Apr; 19(2):535-64. PubMed ID: 15024715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
